We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIOT
1001
PowerFleet Inc
AIOT
$592M
$335K 0.01%
108,900
-18,800
-15% -$54.2K
IMPL
1002
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$333K 0.01%
68,300
-10,000
-13% -$76.6K
WTT
1003
DELISTED
Wireless Telecom Group, Inc.
WTT
$333K 0.01%
256,258
LGL icon
1004
LGL Group
LGL
$46.5M
$331K 0.01%
77,438
SUP
1005
DELISTED
Superior Industries International
SUP
$331K 0.01%
109,600
VLDR
1006
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$331K 0.01%
+350,000
New +$409K
SEM
1007
DELISTED
Select Medical
SEM
$329K 0.01%
27,654
PXLW icon
1008
Pixelworks
PXLW
$41.6M
$328K 0.01%
16,958
+6,250
+58% +$149K
LONA
1009
LeonaBio Inc
LONA
$72.1M
$327K 0.01%
+11,010
New +$380K
BRID icon
1010
Bridgford Foods
BRID
$56.5M
$327K 0.01%
23,100
DMRA
1011
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$327K 0.01%
6,924
IMA
1012
ImageneBio Inc
IMA
$64.6M
$326K 0.01%
7,650
+6,567
+606% +$380K
KULR icon
1013
KULR Technology Group
KULR
$135M
$326K 0.01%
31,875
GRTX
1014
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$325K 0.01%
187,000
GRTS
1015
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$324K 0.01%
126,000
+102,900
+445% +$328K
ANVS icon
1016
Annovis Bio
ANVS
$80M
$323K 0.01%
23,600
QTTB icon
1017
Q32 Bio
QTTB
$464M
$321K 0.01%
11,083
+5,555
+100% +$227K
ATXS
1018
DELISTED
Astria Therapeutics
ATXS
$316K 0.01%
35,000
-79,279
-69% -$531K
VOR icon
1019
Vor Biopharma
VOR
$1.28B
$316K 0.01%
3,970
+500
+14% +$49.2K
OMER icon
1020
Omeros
OMER
$959M
$315K 0.01%
+100,000
New +$464K
PRTK
1021
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$315K 0.01%
122,700
DXLG icon
1022
Destination XL Group
DXLG
$35.4M
$314K 0.01%
58,000
-5,900
-9% -$28.1K
BCML icon
1023
BayCom
BCML
$333M
$313K 0.01%
17,813
-28,500
-62% -$551K
RVP icon
1024
Retractable Technologies
RVP
$20.1M
$313K 0.01%
158,134
+89,134
+129% +$310K
SPIR icon
1025
Spire Global
SPIR
$555M
$313K 0.01%
+36,250
New +$393K

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.